Hyalo Technologies, founded by Shalabh Jain, has been awarded 2015 Healthcare Innovators Awards during a solemn ceremony. The award, sponsored by prestigious companies and organizations, such as the Philadelphia Business Journal, Comcast, Independence Blue Cross, & Pennsylvania BIO, recognized individuals, companies and products that are leading the pack in health care and life sciences and are bringing innovation to the Greater Philadelphia area’s community.
The awards ceremony attended by leaders from across the nation in the healthcare, technology and business was held at a cocktail reception awards program on October 22, 2015 at the Crystal Tea Room at the Wanamaker Building in Philadelphia, PA.
“The hard work, innovation and achievements of my entire team has paid off,: said, Shalabh Jain, Entrepreneur, Founder, and Chairman & CEO of Hyalo Technologies, after receiving the award. “It’s indeed an honor for me and my dedicated team at Hyalo Technologies, founded in 2013,” he said with a sens of pride.
Son of immigrants of Indian origin from New Jersey, this young and talented youth decided on becoming an entrepreneur after attending medical school. Instead taking the traditional route of practicing medicine, Shalabh Jain founded Hyalo Technologies. His vision was to launch a Biopharmaceutical company that establishes the next generation of drug delivery. His newly founded company strives to leverage technology and research to effectively enhance efficacy and therapeutic effect.
According to Shalabh, “Through its innovative biodegradable drug delivery system, the HyaloSphere, Hyalo Technologies drastically reduces systemic side effects and increases patient compliance.” The HyaloSphere, known to be the only drug delivery system that offers the combination of nanotechnology, timed-controlled drug release, target specific drug delivery, sequential drug delivery intelligence, an accelerated healing process, and 100% biodegradable layers. Applications for this drug delivery system can range from, but are not limited to: cancer, pain management, vaccinations, bacterial infections, diabetes, psychiatric disorders & skin diseases.
Success does not come easily. Shalbh had a clear vision and he had planned everything in his mind, before venturing into this new startup. Utilizing his background in pharmaceutical sciences and medicine, along with his life savings from jobs working as a student, he set out to persuade his very first investors.
After successfully obtaining seed funding, in the end of 2013, Shalabh spent the next year and half beginning his research & development in Switzerland, and procuring raw materials, as well as specialized lab equipment.
In 2014, Hyalo Technologies was finally up and running at the startup incubator located at the University City Science Center on UPENN’s campus in Philadelphia, PA. The next step was to build a team to carry out research & development of the HyaloSphere. Shalabh recruited his former college professors from the Philadelphia College of Pharmacy at the University of the Sciences in Philadelphia. In addition, the company convinced seasoned pharmaceutical executives with more than 25 years of experience in the industry to join Hyalo Technologies. “These experts in drug delivery, pharmaceutical development, and corporate business have come together to make the dream of Hyalo Technologies into reality,” Shalabh says.
In the last year under the leadership of the company’s visionary leader, Shalabh Jain, Hyalo Technologies research & development program has made progressive strides, and through its rigorous research and development. Hyalo Technologies has established a unique proprietary process to produce the HyaloSphere and a pipeline of new products. Currently the company is in advanced research stages, has filed for several patents on new technologies, and is on route to clinical trials for several of these products.
Shalabh hopes to take this company to the next level. The company is in current business decisions with major American, European, Indian, and Asian pharmaceutical and biotech companies.
This young and confident Entrepreneur is seeking collaboration from anyone who can be part of his endeavors. “Hyalo Technologies is open to collaborations such as Joint Ventures, strategic partnerships, and licensure deals with established biotech and pharmaceutical companies to produce and market their products globally.”
